Inst. Alexander Fleming

Buenos Aires C1426ANZ

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Carcinoma, Renal Cell

Studies at this site

• A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer — Recruiting now
• A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment — Stopped early